Repertoire Immune Medicines, the startup formed in 2020 from the merging of two Flagship Pioneering companies, has scrapped its two lead drugs, replaced its CEO and laid off 65 people — nearly half its staff.
Repertoire Immune Medicines, the startup formed in 2020 from the merging of two Flagship Pioneering companies, has scrapped its two lead drugs, replaced its CEO and laid off 65 people — nearly half its staff.
About Our Site:
The primary purpose of the site is to provide Real Estate & Mortgage information as it relates to today’s business environment. It can also be used to answer related question you might have about buying, selling, or financing real estate.